Literature DB >> 28275078

Slow Clearance of Norovirus following Infection with Emerging Variants of Genotype GII.4 Strains.

Lars Gustavsson1, Rickard Nordén2, Johan Westin2, Magnus Lindh2, Lars-Magnus Andersson2.   

Abstract

The emergence of new norovirus genotype GII.4 strains is associated with widespread norovirus epidemics. Extended periods of viral shedding can contribute to the epidemic potential of norovirus. To describe the duration of viral shedding in infections with novel emerging GII.4 strains versus infections with previously circulating strains, we performed a prospective cohort study of patients hospitalized with norovirus gastroenteritis during separate winter seasons. Rectal swab samples were obtained at the time of inclusion and weekly during follow-ups. The subgenotype strain was determined from capsid sequences. The outcome was defined by the detection of virus for >14 days (slow clearance) or by the detection of negative samples within 14 days (rapid clearance). Two major epidemic GII.4 strains emerged during the study period, GII.4 New Orleans 2009, in 2010, and GII.4 Sydney 2012, in 2012. From these two seasons, sequences were available from 24 cases where the duration of shedding could be determined. The median age of the patients was 83 years and 50% were women. The majority of patients were infected with virus that clustered with the respective season's epidemic strain (n = 19), whereas 5 patients had previously circulating strains (3 were Den Haag 2006b, in 2010, and 2 were New Orleans 2009, in 2012). Among the patients infected with an epidemic strain, the proportion who shed virus for >14 days was significantly higher (16/19 [84%] versus 1/5 [20%], P = 0.01). In summary, a slow clearance of norovirus from stool was more common in infections with novel epidemic GII.4 strains. This suggests that the average duration of shedding may be longer during seasons when new GII.4 strains have emerged.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  elderly; gastroenteritis; norovirus; strain; viral shedding

Mesh:

Substances:

Year:  2017        PMID: 28275078      PMCID: PMC5405271          DOI: 10.1128/JCM.00061-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  Rational optimization of generic primers used for Norwalk-like virus detection by reverse transcriptase polymerase chain reaction.

Authors:  H Vennema; E de Bruin; M Koopmans
Journal:  J Clin Virol       Date:  2002-08       Impact factor: 3.168

2.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.

Authors:  Koichiro Tamura; Daniel Peterson; Nicholas Peterson; Glen Stecher; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2011-05-04       Impact factor: 16.240

3.  Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity.

Authors:  Timothy J Nice; Megan T Baldridge; Broc T McCune; Jason M Norman; Helen M Lazear; Maxim Artyomov; Michael S Diamond; Herbert W Virgin
Journal:  Science       Date:  2014-11-27       Impact factor: 47.728

4.  Rectal swabs can be used for diagnosis of viral gastroenteritis with a multiple real-time PCR assay.

Authors:  Lars Gustavsson; Johan Westin; Lars-Magnus Andersson; Magnus Lindh
Journal:  J Clin Virol       Date:  2011-06-16       Impact factor: 3.168

5.  Duration of norovirus excretion and the longitudinal course of viral load in norovirus-infected elderly patients.

Authors:  Y Aoki; A Suto; K Mizuta; T Ahiko; K Osaka; Y Matsuzaki
Journal:  J Hosp Infect       Date:  2010-03-21       Impact factor: 3.926

6.  A single amino acid substitution in the murine norovirus capsid protein is sufficient for attenuation in vivo.

Authors:  D Bailey; L B Thackray; I G Goodfellow
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

7.  Disease course and viral shedding in experimental Norwalk virus and Snow Mountain virus infection.

Authors:  A E Kirby; J Shi; J Montes; M Lichtenstein; C L Moe
Journal:  J Med Virol       Date:  2014-02-14       Impact factor: 2.327

Review 8.  Heterogeneity in norovirus shedding duration affects community risk.

Authors:  M O Milbrath; I H Spicknall; J L Zelner; C L Moe; J N S Eisenberg
Journal:  Epidemiol Infect       Date:  2013-03-18       Impact factor: 4.434

9.  Analysis of amino acid variation in the P2 domain of the GII-4 norovirus VP1 protein reveals putative variant-specific epitopes.

Authors:  David J Allen; Jim J Gray; Chris I Gallimore; Jacqueline Xerry; Miren Iturriza-Gómara
Journal:  PLoS One       Date:  2008-01-23       Impact factor: 3.240

10.  Emergence of the GII-4 Norovirus Sydney2012 strain in England, winter 2012-2013.

Authors:  David J Allen; Natalie L Adams; Farah Aladin; John P Harris; David W G Brown
Journal:  PLoS One       Date:  2014-02-13       Impact factor: 3.240

View more
  6 in total

1.  A Secreted Viral Nonstructural Protein Determines Intestinal Norovirus Pathogenesis.

Authors:  Sanghyun Lee; Hejun Liu; Craig B Wilen; Zoi E Sychev; Chandni Desai; Barry L Hykes; Robert C Orchard; Broc T McCune; Ki-Wook Kim; Timothy J Nice; Scott A Handley; Megan T Baldridge; Gaya K Amarasinghe; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2019-05-23       Impact factor: 21.023

2.  The Norovirus Epidemiologic Triad: Predictors of Severe Outcomes in US Norovirus Outbreaks, 2009-2016.

Authors:  Rachel M Burke; Minesh P Shah; Mary E Wikswo; Leslie Barclay; Anita Kambhampati; Zachary Marsh; Jennifer L Cannon; Umesh D Parashar; Jan Vinjé; Aron J Hall
Journal:  J Infect Dis       Date:  2019-04-16       Impact factor: 5.226

3.  Norovirus Cell Tropism Is Determined by Combinatorial Action of a Viral Non-structural Protein and Host Cytokine.

Authors:  Sanghyun Lee; Craig B Wilen; Anthony Orvedahl; Broc T McCune; Ki-Wook Kim; Robert C Orchard; Stefan T Peterson; Timothy J Nice; Megan T Baldridge; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2017-09-28       Impact factor: 21.023

4.  Estimating the incidence of norovirus acute gastroenteritis among US and European international travelers to areas of moderate to high risk of traveler's diarrhea: a prospective cohort study protocol.

Authors:  Lisa Lindsay; Herbert L DuPont; Christine L Moe; Martin Alberer; Christoph Hatz; Amy E Kirby; Henry M Wu; Thomas Verstraeten; Robert Steffen
Journal:  BMC Infect Dis       Date:  2018-12-03       Impact factor: 3.090

Review 5.  Genetic Susceptibility to Human Norovirus Infection: An Update.

Authors:  Johan Nordgren; Lennart Svensson
Journal:  Viruses       Date:  2019-03-06       Impact factor: 5.048

6.  Long Term Norovirus Infection in a Patient with Severe Common Variable Immunodeficiency.

Authors:  Loa Ottosson; Marie Hagbom; Rikard Svernlöv; Sofia Nyström; Beatrice Carlsson; Mattias Öman; Magnus Ström; Lennart Svensson; Åsa Nilsdotter-Augustinsson; Johan Nordgren
Journal:  Viruses       Date:  2022-08-02       Impact factor: 5.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.